[1] |
ZHOU XX, HE RX, PU XY, et al. Clinical characteristics of the Wilson disease carrier[J]. Natl Med J China, 2019, 99(11): 806-811. DOI: 10.3760/cma.j.issn.0376-2491.2019.11.002.
周香雪, 何荣兴, 蒲小勇, 等. 肝豆状核变性携带者的临床特点及治疗策略[J]. 中华医学杂志, 2019, 99(11): 806-811. DOI: 10.3760/cma.j.issn.0376-2491.2019.11.002.
|
[2] |
HUANG Y, LIU ZF. Research advance of ATP7B gene mutation in hepatolenticular degeneration[J]. Med Recapitulate, 2019, 25(9): 1717-1721. DOI: 10.3969/j.issn.1006-2084.2019.09.010.
黄艳, 刘志峰. 肝豆状核变性ATP7B基因突变的研究进展[J]. 医学综述, 2019, 25(9): 1717-1721. DOI: 10.3969/j.issn.1006-2084.2019.09.010.
|
[3] |
POLISHCHUK EV, CONCILLI M, IACOBACCI S, et al. Wilson disease protein ATP7B utilizes lysosomal exocytosis to maintain copper homeostasis[J]. Dev Cell, 2014, 29(6): 686-700. DOI: 10.1016/j.devcel.2014.04.033.
|
[4] |
CLEYMAET S, NAGAYOSHI K, GETTINGS E, et al. A review and update on the diagnosis and treatment of neuropsychiatric Wilson disease[J]. Expert Rev Neurother, 2019, 19(11): 1117-1126. DOI: 10.1080/14737175.2019.1645009.
|
[5] |
DONG Y, NI W, CHEN WJ, et al. Spectrum and classification of ATP7B variants in a large cohort of Chinese patients with Wilson's disease guides genetic diagnosis[J]. Theranostics, 2016, 6(5): 638-649. DOI: 10.7150/thno.14596.
|
[6] |
van den BERGHE PV, STAPELBROEK JM, KRIEGER E, et al. Reduced expression of ATP7B affected by Wilson disease-causing mutations is rescued by pharmacological folding chaperones 4-phenylbutyrate and curcumin[J]. Hepatology, 2009, 50(6): 1783-1795. DOI: 10.1002/hep.23209.
|
[7] |
LIU Y, ZHU H, LI RM, et al. Role of SREBP1 in lipid metabolism of hepatolenticular degeneration and effects of Yinchen Wuling Powder[J]. China J Tradit Chin Med Pharma, 2020, 35(1): 346-349.
刘宇, 朱宏, 李若梦, 等. 固醇调节因子结合蛋白-1在肝豆状核变性脂代谢中的作用及茵陈五苓散对其影响的研究[J]. 中华中医药杂志, 2020, 35(1): 346-349.
|
[8] |
EINER C, LEITZINGER C, LICHTMANNEGGER J, et al. A High-calorie diet aggravates mitochondrial dysfunction and triggers severe liver damage in Wilson disease rats[J]. Cell Mol Gastroenterol Hepatol, 2019, 7(3): 571-596. DOI: 10.1016/j.jcmgh.2018.12.005.
|
[9] |
LIU J, GHAZIANI TT, WOLF JL. Acute fatty liver disease of pregnancy: Updates in pathogenesis, diagnosis, and management[J]. Am J Gastroenterol, 2017, 112(6): 838-846. DOI: 10.1038/ajg.2017.54.
|
[10] |
KEGLEY KM, SELLERS MA, FERBER MJ, et al. Fulminant Wilson's disease requiring liver transplantation in one monozygotic twin despite identical genetic mutation[J]. Am J Transplant, 2010, 10(5): 1325-1329. DOI: 10.1111/j.1600-6143.2010.03071.x.
|
[11] |
CZȽONKOWSKA A, LITWIN T. Wilson disease - currently used anticopper therapy[J]. Handb Clin Neurol, 2017, 142: 181-191. DOI: 10.1016/B978-0-444-63625-6.00015-X.
|
[12] |
MOINI M, TO U, SCHILSKY ML. Recent advances in Wilson disease[J]. Transl Gastroenterol Hepatol, 2021, 6: 21. DOI: 10.21037/tgh-2020-02.
|
[13] |
ALA A, ALIU E, SCHILSKY ML. Prospective pilot study of a single daily dosage of trientine for the treatment of Wilson disease[J]. Dig Dis Sci, 2015, 60(5): 1433-1439. DOI: 10.1007/s10620-014-3495-6.
|
[14] |
ZHOU SM, GUO LP, CAI WF, et al. Latest advances in the treatment of hepatolenticular degeneration[J]. J Clin Hepatol, 2020, 36(1): 218-221. DOI: 10.3969/j.issn.1001-5256.2020.01.052.
周思敏, 郭丽萍, 蔡王锋, 等. 肝豆状核变性的治疗现状[J]. 临床肝胆病杂志, 2020, 36(1): 218-221. DOI: 10.3969/j.issn.1001-5256.2020.01.052.
|
[15] |
XIAO QQ, FAN JG. Advances in the treatment of Wilson Disease[J]. Chin J Hepatol, 2021, 29(1): 79-82. DOI: 10.3760/cma.j.cn501113-20201018-00559.
肖倩倩, 范建高. 肝豆状核变性的治疗进展[J]. 中华肝脏病杂志, 2021, 29(1): 79-82. DOI: 10.3760/cma.j.cn501113-20201018-00559.
|